Company profile

Precision AI Pty

Population Health & Healthcare Analytics

Company profile

About Precision AI Pty

precision-health.ai is a Norwegian health AI company on a mission to make precision health part of routine patient care and improve health outcomes at the population level. Built on decades of research and development, the company delivers AI-powered clinical decision support (CDSS) tools for primary care physicians and specialists to address high-value clinical challenges. Their cloud-based platform integrates multimodal health data—including genetics, advanced imaging biomarkers, lab results, and electronic health records—to empower clinicians to make better informed decisions, improve outcomes, and redefine patient care. The company focuses on three primary clinical domains: neurology (Alzheimer's and dementia risk stratification and differential diagnosis), oncology (prostate cancer contouring and women's pelvic disease diagnosis), and psychiatry (cardiovascular disease risk assessment for patients with severe mental illness and medication response optimization). Developed in collaboration with practicing clinicians and researchers, precision-health.ai combines validated AI approaches with advanced imaging techniques like Restriction Spectrum Imaging (RSI) to deliver scalable diagnostic solutions. The company is actively involved in multiple EU Horizon 2020 research projects and collaborations with leading academic institutions.

Company description Precision AI Pty official website

Primary marketPopulation Health & Healthcare Analytics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Precision AI Pty?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Alzheimer's disease
  • cardiovascular disease comorbidities in mental illness
  • dementia
  • endometriosis
  • frontotemporal dementia
  • Lewy body dementia
  • ovarian cancer
  • prostate cancer
  • severe mental disorders
  • vascular dementia

Who it serves

  • municipality health services
  • neurologists
  • primary care physicians
  • psychiatrists
  • radiation oncologists
  • specialists

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsEurope · Norway
Company sourceOfficial website

Company milestones

Platform expansion

Active participation in multiple EU Horizon 2020 projects (2023-2027): REALMENT for medication response prediction, CoMorMent for CVD risk in mental illness, and AGECare for dementia diagnosis in municipalities. Phase III RCT validation of prostate cancer contouring solution.

Partnerships

Recorded partners

  • EU Horizon 2020 consortium partners
  • J. Craig Venter Institute
  • NORMENT (Norwegian Center for Research in Mental Disorders)
  • Oslo University Hospital
  • University of Oslo (UiO)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Alzheimer's & Dementia Risk Stratification CDSS

5-15 year risk stratification for Alzheimer's and related dementias in primary care

Software · Cloud SaaSCompany source

CVD Risk Calculator for Severe Mental Illness

Cardiovascular risk assessment tool for patients with severe mental illnesses

Software · Cloud SaaSCompany source

Differential Diagnosis CDSS for Alzheimer's & Dementias

Distinguish between Alzheimer's disease and different dementia subtypes at early stages

Software · Cloud SaaSCompany source

Prostate Cancer Contouring with RSI-Score

AI-powered prostate tumor contouring for precision radiation boost therapy

Software · Cloud SaaSCompany source

Psychiatric Medication Response CDSS

Predict medication response and adverse effects for mental health patients

Platform · Cloud SaaSCompany source

Women's Pelvic Disease Diagnostic CDSS

Non-invasive AI diagnostic tool to distinguish endometriosis from ovarian cancer

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

Precision AI Surgical Planning System (PAI-SPS)

K251558 · 510k · Jan 12, 2026

Precision AI Surgical Planning System (PAI-SPS)

K243955 · 510k · Jan 21, 2025

Precision AI Surgical Planning System (PAI-SPS)

K233992 · 510k · Aug 5, 2024

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

5-15 year risk stratification for Alzheimer's and dementia

Scalable solution for primary care physicians

Improved contour accuracy for prostate tumors

Radiation oncologists using RSI maps for focal boost radiation treatment

Optimized medication prescriptions

Minimize side effects and improve outcomes in shorter time for mental health patients

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Anders M. Dale

Founder & CEO

Ole A. Andreassen

Chief Medical Advisor

Anna C. Czerwinska

General Manager

Oleksandr Frei

Chief Technology Officer

06 · Company updates

Updates from Precision AI Pty

Recent articles published on Precision AI Pty's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Population Health & Healthcare Analytics

Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon